Foster & Motley Inc. decreased its holdings in shares of Aetna Inc (NYSE:AET) by 3.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,946 shares of the company’s stock after selling 317 shares during the period. Foster & Motley Inc.’s holdings in Aetna were worth $1,794,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in AET. Janus Henderson Group PLC lifted its stake in Aetna by 9,446.2% during the second quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock worth $657,255,000 after purchasing an additional 4,283,553 shares during the period. Capital World Investors lifted its stake in Aetna by 8.9% during the second quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after purchasing an additional 1,688,767 shares during the period. Orbimed Advisors LLC lifted its stake in Aetna by 57.3% during the third quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock worth $222,057,000 after purchasing an additional 508,600 shares during the period. Samlyn Capital LLC bought a new position in Aetna during the second quarter worth about $77,170,000. Finally, Point72 Asset Management L.P. lifted its stake in Aetna by 233.9% during the third quarter. Point72 Asset Management L.P. now owns 429,353 shares of the company’s stock worth $68,271,000 after purchasing an additional 300,753 shares during the period. Hedge funds and other institutional investors own 87.88% of the company’s stock.

Shares of Aetna Inc (AET) opened at $189.34 on Tuesday. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 0.52. The firm has a market cap of $61,255.16, a P/E ratio of 35.06, a P/E/G ratio of 1.59 and a beta of 0.61. Aetna Inc has a fifty-two week low of $116.04 and a fifty-two week high of $192.37.

Aetna (NYSE:AET) last issued its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share for the quarter, beating analysts’ consensus estimates of $2.06 by $0.39. The business had revenue of $14.99 billion during the quarter, compared to analyst estimates of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. Aetna’s revenue for the quarter was down 5.0% compared to the same quarter last year. During the same quarter last year, the business posted $2.07 earnings per share. research analysts expect that Aetna Inc will post 9.78 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Thursday, January 11th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.06%. The ex-dividend date of this dividend is Wednesday, January 10th. Aetna’s dividend payout ratio is currently 37.04%.

A number of research analysts have commented on AET shares. Zacks Investment Research upgraded shares of Aetna from a “hold” rating to a “buy” rating and set a $174.00 price target for the company in a research note on Thursday, October 12th. ValuEngine raised shares of Aetna from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Piper Jaffray Companies raised shares of Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 price objective for the company in a report on Wednesday, January 3rd. Argus lowered shares of Aetna from a “buy” rating to a “hold” rating and set a $185.00 price objective for the company. in a report on Wednesday, December 6th. Finally, Morgan Stanley lowered shares of Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 price objective for the company. in a report on Wednesday, December 20th. Eleven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $175.09.

ILLEGAL ACTIVITY NOTICE: This piece of content was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://theolympiareport.com/2018/01/23/foster-motley-inc-has-1-79-million-holdings-in-aetna-inc-aet.html.

Aetna Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.